George N. Naumov

LKB1 modulates lung cancer differentiation and metastasis

Hongbin Ji, Matthew R. Ramsey, D. Neil Hayes et al. · Nature · 2007 · 1.1K citations

Medicine, Cancer Biology, Oncology +11

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR</i> and <i>ERBB2</i> Mutations that Are Resistant to Gefitinib

Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale et al. · Cancer Research · 2007 · 718 citations · Full text

Medicine, Oncology, Pharmacology +13

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu et al. · Journal of Clinical Investigation · 2006 · 457 citations · Full text

Medicine, Oncology, Pharmacology +17

A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

George N. Naumov, Elise R. Bender, David Zurakowski et al. · JNCI Journal of the National Cancer Institute · 2006 · 417 citations · Full text

Medicine, Cell Biology, Oncology +17

Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.

George N. Naumov, Ian C. MacDonald, Pascal M Weinmeister et al. · PubMed · 2002 · 349 citations

Medicine, Cancer Biology, Oncology +17